152 related articles for article (PubMed ID: 8333037)
1. Effects of rapamycin in experimental organ allografting.
Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K
Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
3. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
5. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
[TBL] [Abstract][Full Text] [Related]
8. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
10. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
12. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
[TBL] [Abstract][Full Text] [Related]
13. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
[No Abstract] [Full Text] [Related]
14. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.
Luo L; Sun Z; Luo G
J Surg Res; 2013 Jan; 179(1):e255-63. PubMed ID: 22480837
[TBL] [Abstract][Full Text] [Related]
16. The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat.
Levy AE; Alexander JW
Transplantation; 1996 Jul; 62(2):262-6. PubMed ID: 8755826
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
[No Abstract] [Full Text] [Related]
19. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.
Stepkowski SM; Chen H; Daloze P; Kahan BD
Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691
[TBL] [Abstract][Full Text] [Related]
20. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
